Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Product Recalls by Year
Novartis Total Product Recalls: 7 in FY2025, up 75.0% from a year earlier.
Latest, FY2025
7
Period ended Dec 31, 2025
Change on a year earlier
+75.0%
4 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
“| Total recalls | 7 | 4 | ∆ | 28 |”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025 & Nonfinancial Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Product Recalls | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | +75.0% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 4 | -60.0% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2023 | Dec 31, 2023 | 10 | +42.9% | Novartis Form 6-K (0001370368-25-000008) ↗ |
| FY2022 | Dec 31, 2022 | 7 | – | Novartis Form 6-K (0001370368-25-000008) ↗ |
Breakdown
What makes up total Product Recalls
Cite this data
StockData. (2026). Novartis Total Product Recalls, annual FY2022–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/qual-recalls-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.